The global clinical trials supply and logistics market size was calculated at USD 4,310 million in 2024 and is predicted to attain around USD 9,290 million by 2034, expanding at a CAGR of 7.98% from 2025 to 2034.
Highlights of the Clinical Trial Supply And Logistics Market
- North America held a significant share of the clinical trial supply and logistics market in 2024.
- Asia Pacific is projected to host the fastest-growing market in the coming years.
- By service, the logistics & distribution segment underwent notable growth in the clinical trial supply and logistics market in 2024.
- By service, the manufacturing segment will gain a significant share of the market over the studied period of 2025 to 2034.
- By phase, the phase III segment enjoyed a prominent position in the clinical trial supply and logistics market during 2024.
- By phase, the phase II segment is predicted to witness significant growth in the market over the forecast period.
- By end user, the pharmaceuticals segment captured a significant portion of the clinical trial supply and logistics market in 2024.
- By end user, the biologicals segment is projected to expand rapidly in the market in the coming years.
- By therapeutic area, the cardiovascular diseases segment maintained a leading position in the clinical trial supply and logistics market in 2024.
- By therapeutic area, the oncology segment is anticipated to grow with the highest CAGR in the market during the studied years.
Industry Valuation and Growth Rate Projection
| Industry Worth |
Details |
| Market Size in 2025 |
USD 4,650 Million |
| Market Size by 2034 |
USD 9,290 Million |
| Market Growth Rate from 2025 to 2034 |
CAGR of 7.98% |
The clinical trial supply and logistics market refers to the production, distribution, and use of clinical trial supply and logistics, in which clinical trial supplies are investigational products like biologic substances, medical devices, or drugs that are used in clinical trials for evaluating their effectiveness and safety. Clinical trial logistics is about making sure everything required for a clinical trial gets where it needs to go. It includes coordinating and managing resources, procedures, and materials involved in distributing supplies, storing, and moving for clinical trials.
A rising number of clinical trials is leading to a need for clinical trial supply and logistics. According to a report published in December 2024 by the World Health Organization, the number of clinical trials by country was, United States (186497 trials), China (135747), India (74031), Japan (65167), Germany (54902), and France (46309).
- In March 2025, Sofia, a new AI assistant, to simplify the management of clinical trials was launched by a global clinical trial technology company that specializes in critical studies in therapeutic areas like rare disease, oncology, and central nervous system (CNS), Suvoda, LLC.
Clinical Trial Supply And Logistics Market: Stats and Figures
- In August 2024, the need for local clinical trials for many drugs in India was waived by the central government. Medicines that are already approved by regulatory authorities, according to official sources, in countries like the EU, the US, and the UK, and are not readily available in India, are now exempt from the need for local trials.
- According to a report published in August 2023 by the Government of India, of study on the CRO sector in India was conducted by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. India CRO Market, By service type. The Indian Pharmaceutical CRO market is classified into 4 categories by board service types, including integrated drug discovery and development (20%), pre-clinical (8%), BA/BE + clinical trials (18%), and clinical trials (Phase I to IV) (54%).
Industry Leader Announcements
- Alan Almstrong, Chairman and CEO, Almac Group
Alan Almstrong, Chairman and CEO, Almac Group, said, “As we support our partners in delivering life-saving medicines across the globe, we are conscious of our impact on the people and world around us”.
- Charlotte Moser, MD, PhD, MBA, appointed as Chief Medical Officer
Dr. Moser said, “I am delighted to join an organization at the forefront of patient-focused drug development and healthcare innovation, with differentiated expertise in meeting the needs of life sciences customers worldwide.”
How Has AI Benefitted the Market
AI allows the clinical trial supply and logistics market to forecast demand more precisely, reduce supply cycle times, and streamline logistics. Large and mid-size companies using SAP Intelligence Clinical Supply Management have improved their visibility across clinical supply chains, helping them to ensure timely drug delivery and minimize wastage.
- Drug discovery: AI in drug discovery offers many benefits, including allowing personalized medicines, enhancing the success rate of clinical trials, reducing costs, and accelerating the process.
- Supply chain management: AI in supply chain management includes applications like freight bill auditing, warehouse automation, demand forecasting, and route optimization.
- Speed up drug discovery: AI can speed up drug discovery, which helps to bring together the atomic structure and 3D geometry of a potential drug-like molecule and build a picture of how it fits into its target protein.
Geographical Insights
In 2024, North America held a significant share of the clinical trial supply and logistics market in 2024. In North America, the United States is the international center for biotechnology and pharmaceutical research and development.
- Strict governmental regulations are driving the growth of the market in the North American region. According to a report published by Deep Pharma Intelligence, showed that the United States is the Global Leader in the geographical landscape of AI adoption in drug discovery. As of 2023, over 50% of all AI-based drug discovery biotechnology companies were based in the United States, followed by 17% in Europe and near about 4% in China.
Asia Pacific
Asia Pacific is projected to host the fastest-growing market in the coming years. The region’s clinical trial supply and logistics market growth is driven by factors including cost benefits, different diseases, and increased patient numbers.
- India’s life science sector is undergoing a major transformation, led by the expansion of Global Capability Centers (GCCs). Innovations in artificial intelligence (AI) are central to this transformation, driving innovation across drug discovery and clinical research.
- In September 2022, the opening of a new clinical trial supplies and logistics depot in Suzhou, China, was announced by a leading global clinical research organization (CRO), Parexel, which focused on the development and delivery of advanced new therapies to enhance patient health.
Recent Developments:
- In November 2024, a Supply Chain Excellence Award USA was earned by a global contract development and manufacturing organization (CDMO), PCI Pharma Services for an advanced digital solution for clinical trials and commercial management.
- In November 2024, the global healthcare supply chain training and consulting program to transform India’s Healthcare Sector was launched by a world leader in supply chain management training and consulting, Blue Ocean Corporation.
Competitive Landscape
The clinical trial supply and logistics market is highly competitive with leading harmaceutical companies such as Thermo Fischer Scientific and Parexel with the largest market share.
The market is dominated by many pharmaceutical companies renowned for their significant contributions to cancer research and treatment. Based on recent data, the top two leading companies are:
- Company Name: Thermo Fischer Scientific
- Year of Incorporation: 2006
- Headquarters: Waltham, Massachusetts, United States
Thermo Fischer Scientific reported complementary segments revenue of $42.88B in 2024 driven by products like Laboratory Products & Biopharma Services (52%), Life Sciences Solutions (21%), Analytical Instruments (17%), and Specialty Diagnostics (10%).
